Korean Mediterranean diet and activity tracking for early blood conditions
Part of Blood & lymphatic, Cancer, Immune system & allergy clinical trials.
This 12-week pilot study tests whether a Korean-style Mediterranean diet, along with daily physical activity tracking, can help people with early blood conditions (MGUS or smoldering myeloma). The goal is to see if this approach is safe and may slow or prevent the condition from getting worse.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be between 19 and 80 years old.
- Have a diagnosis of MGUS (monoclonal gammopathy of undetermined significance) or smoldering multiple myeloma (SMM) — early precancerous conditions of the blood.
- Be willing to eat a Mediterranean-style diet with Korean foods for 12 weeks.
- Have access to and be able to use a smartphone and a wearable device to track daily steps and activity.
- Be able to keep study appointments and provide blood, stool, and questionnaire samples.
- Not be currently receiving treatment for active multiple myeloma.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a plant-based diet and certain supplements can help people with smoldering multiple myeloma (SMM) or monoclonal gammopathy of undetermined significance (MGUS). Participants will learn to cook plant-based recipes and track their meals using a phone app.
This trial tests whether a whole-food, plant-based eating pattern—plus supplements or placebo—can improve health outcomes in people with MGUS or smoldering multiple myeloma. You may be asked to follow specific recipes and stop certain supplements, so it helps to confirm you can stick with the plan.
This study tests whether a 12-month lifestyle program (including diet and exercise) can improve health markers in people with early blood conditions called smoldering myeloma or MGUS. The goal is to see if lifestyle changes can help delay or prevent the disease from getting worse.
This study tests whether a special diet—longer nightly fasting plus a Mediterranean eating pattern—can help people with multiple myeloma or its early stages. If you qualify, you will be randomly assigned to start the diet right away or join a waitlist group.
This is an observational study that follows people with early blood findings that can be linked to multiple myeloma, to understand what happens over time. It does not test a new drug for most people; instead, it tracks health, lab results, and imaging to learn who may develop myeloma.
This study is for people who are newly diagnosed with either a very early blood condition (MGUS or smoldering myeloma) or AL amyloidosis, and who have not yet had treatment. It aims to help doctors better diagnose and manage these conditions in Italy.
Hear when a new Monoclonal Gammopathy of Undetermined Significance trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.